Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | PKM | P14618 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL29204953 | 0.97 | CYP1A2 (0.31) | CYP1A2PKM | |
| SCHEMBL1835132 | 0.92 | ALDH1A1 (0.34) | TSHR | |
| SCHEMBL1832603 | 0.90 | TSHR (0.38) | TSHR | |
| SCHEMBL1835105 | 0.90 | TSHR (0.38) | TSHR | |
| SCHEMBL1831750 | 0.90 | TSHR (0.38) | TSHR | |
| SCHEMBL6296129 | 0.90 | TSHR (0.38) | TSHR | |
| SCHEMBL28170888 | 0.88 | ALDH1A1 (0.32) | TSHR | |
| Hydrochloric Acid SCHEMBL31094678 | 0.88 | DNM1 (0.39) | TSHR | |
| SCHEMBL5288516 | 0.84 | — | — | |
| SCHEMBL5287489 | 0.84 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11996557-B2 | Direct regeneration of lithium ion cathodes by ionothermal relithiation | UT-BATTELLE, LLC (US) | 2024-05-28 | — | — | US | disclosed |
| CN-111117594-B | Electrochromic material and electrochromic device based on dynamic metal-ligand complexation | 吉林大学 | 2024-03-26 | — | — | CN | disclosed |
| US-11795583-B2 | Plasticized melt spinning process using ionic liquids for production of polyacrylonitrile fibers | UT-BATTELLE, LLC (US) | 2023-10-24 | — | — | US | disclosed |
| US-20220376240-A1 | DIRECT REGENERATION OF LITHIUM ION CATHODES BY IONOTHERMAL RELITHIATION | U. S. DEPARTMENT OF ENERGY | 2022-11-24 | — | — | US | disclosed |
| US-20220235493-A1 | PLASTICIZED MELT SPINNING PROCESS USING IONIC LIQUIDS FOR PRODUCTION OF POLYACRYLONITRILE FIBERS | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION | 2022-07-28 | — | — | US | disclosed |
| US-11251433-B2 | Nitrogen-sulfur-carbon nanocomposites and their application as cathode materials in lithium-sulfur batteries | UT-BATTELLE, LLC (US) | 2022-02-15 | — | — | US | disclosed |
| US-11186893-B2 | Rare earth amide compositions | UT-BATTELLE, LLC (US) | 2021-11-30 | — | — | US | disclosed |
| US-20200370144-A1 | METHODS FOR LIQUID EXTRACTION OF RARE EARTH METALS USING IONIC LIQUIDS | UT-BATTELLE, LLC (US) | 2020-11-26 | — | — | US | disclosed |
| US-10689727-B2 | Methods for liquid extraction of rare earth metals using ionic liquids | UT-BATTELLE, LLC (US) | 2020-06-23 | — | — | US | disclosed |
| US-20180309130-A1 | NITROGEN-SULFUR-CARBON NANOCOMPOSITES AND THEIR APPLICATION AS CATHODE MATERIALS IN LITHIUM-SULFUR BATTERIES | UT-BATTELLE, LLC (US) | 2018-10-25 | — | — | US | disclosed |
| EP-2410601-A1 | IONIC LIQUID, ELECTROLYTE, LITHIUM SECONDARY BATTERY COMPRISING SAME, AND PROCESS FOR PRODUCING IONIC LIQUID | The Nippon Synthetic Chemical Industry Co., Ltd. (JP) | 2012-01-25 | — | — | EP | disclosed |
| US-20110311865-A1 | IONIC LIQUID, ELECTROLYTE, LITHIUM SECONDARY BATTERY USING THE SAME, AND PROCESS FOR PRODUCING IONIC LIQUID | THE NIPPON SYNTHETIC CHEMICAL INDUSTRY CO., LTD. (JP) | 2011-12-22 | — | — | US | disclosed |
| US-7939697-B2 | Fluorinating agent and method for producing fluorine-containing compound using the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-05-10 | — | — | US | disclosed |
| CN-1898187-B | Fluorinating agent and method for producing fluorine-containing compound using same | SUMITOMO CHEMICAL CO | 2010-06-09 | — | — | CN | disclosed |
| US-20090287025-A1 | Fluorinating agent and method for producing fluorine-containing compound using the same | SUMITOMO CHEMICAL COMPANY, LIMITED | 2009-11-19 | — | — | US | disclosed |
| US-7569703-B2 | Fluorinating agent and method for producing fluorine-containing compound using the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2009-08-04 | — | — | US | disclosed |
| CN-101298436-A | Fluorinating agent and method for producing fluorine-containing compound using the same | SUMITOMO CHEMICAL CO (JP) | 2008-11-05 | — | — | CN | disclosed |
| US-20070135634-A1 | Fluorinating agent and method for producing fluorine-containing compound using the same | SUMITOMO CHEMICAL COMPANY, LIMITED | 2007-06-14 | — | — | US | disclosed |
| CN-1898187-A | Fluorinating agent and method for producing fluorine-containing compound using same | SUMITOMO CHEMICAL CO (JP) | 2007-01-17 | — | — | CN | disclosed |
| EP-1698606-A1 | FLUORINATING AGENT AND METHOD FOR PRODUCING FLUORINE-CONTAINING COMPOUND USING SAME | Sumitomo Chemical Company, Limited (JP) | 2006-09-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070135634-A1 | Fluorinating agent and method for producing fluorine-containing compound using the same | AFF1, AFF2, AFF4 | CYP1A2 1775/4885PKM 3571/4885LMNA 858/4885 |
| US-20090287025-A1 | Fluorinating agent and method for producing fluorine-containing compound using the same | AFF1, AFF2, AFF4 | CYP1A2 1775/4885PKM 3571/4885LMNA 858/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.